That is obscene -- $750k?!
The market cap of $120m is really strange. It should rightly be down in the the ~$20m range.
Basically a couple of pre-clinical assets, with a bit of safety work done with no independent evidence of efficacy apart from "Recce says it works", and a history of moving goalposts and burying results.
I think it's only partly explained by the large family holdings and very good marketing to retail investors.
A real head scratcher...
Ann: Appendix 4E and Unaudited Preliminary Report, page-12
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.0¢ |
Change
-0.005(1.08%) |
Mkt cap ! $100.9M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 46.5¢ | 45.5¢ | $215.4K | 467.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 175506 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 104491 | 2 |
View Market Depth
| Last trade - 15.59pm 11/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |